chr4-25657986-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006424.3(SLC34A2):c.-4+2096T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 152,104 control chromosomes in the GnomAD database, including 6,586 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 6586 hom., cov: 32)
Consequence
SLC34A2
NM_006424.3 intron
NM_006424.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.04
Publications
4 publications found
Genes affected
SLC34A2 (HGNC:11020): (solute carrier family 34 member 2) The protein encoded by this gene is a pH-sensitive sodium-dependent phosphate transporter. Phosphate uptake is increased at lower pH. Defects in this gene are a cause of pulmonary alveolar microlithiasis. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, May 2010]
SLC34A2 Gene-Disease associations (from GenCC):
- pulmonary alveolar microlithiasisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.344 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC34A2 | NM_006424.3 | c.-4+2096T>C | intron_variant | Intron 1 of 12 | ENST00000382051.8 | NP_006415.3 | ||
| SLC34A2 | NM_001177998.2 | c.-4+2096T>C | intron_variant | Intron 1 of 12 | NP_001171469.2 | |||
| SLC34A2 | NM_001177999.2 | c.-4+1422T>C | intron_variant | Intron 1 of 12 | NP_001171470.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.265 AC: 40323AN: 151986Hom.: 6580 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
40323
AN:
151986
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.265 AC: 40330AN: 152104Hom.: 6586 Cov.: 32 AF XY: 0.268 AC XY: 19946AN XY: 74360 show subpopulations
GnomAD4 genome
AF:
AC:
40330
AN:
152104
Hom.:
Cov.:
32
AF XY:
AC XY:
19946
AN XY:
74360
show subpopulations
African (AFR)
AF:
AC:
2734
AN:
41538
American (AMR)
AF:
AC:
5377
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1192
AN:
3470
East Asian (EAS)
AF:
AC:
1463
AN:
5168
South Asian (SAS)
AF:
AC:
1653
AN:
4814
European-Finnish (FIN)
AF:
AC:
3752
AN:
10562
Middle Eastern (MID)
AF:
AC:
102
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23130
AN:
67960
Other (OTH)
AF:
AC:
635
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1428
2855
4283
5710
7138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
426
852
1278
1704
2130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1076
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.